Traders purchased shares of Zoetis Inc (NYSE:ZTS) on weakness during trading on Friday following insider selling activity. $62.15 million flowed into the stock on the tick-up and $50.99 million flowed out of the stock on the tick-down, for a money net flow of $11.16 million into the stock. Of all stocks tracked, Zoetis had the 32nd highest net in-flow for the day. Zoetis traded down ($0.07) for the day and closed at $91.47Specifically, insider Catherine A. Knupp sold 46,816 shares of the firm’s stock in a transaction on Wednesday, August 15th. The shares were sold at an average price of $90.84, for a total value of $4,252,765.44. Following the completion of the sale, the insider now owns 81,640 shares in the company, valued at approximately $7,416,177.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Roxanne Lagano sold 2,000 shares of the firm’s stock in a transaction on Monday, July 2nd. The stock was sold at an average price of $84.76, for a total transaction of $169,520.00. Following the completion of the sale, the insider now owns 22,023 shares of the company’s stock, valued at approximately $1,866,669.48. The disclosure for this sale can be found here. Insiders sold a total of 197,099 shares of company stock valued at $17,978,939 in the last 90 days. Company insiders own 0.35% of the company’s stock.

ZTS has been the subject of several recent analyst reports. Cantor Fitzgerald set a $90.00 target price on shares of Zoetis and gave the stock a “buy” rating in a research note on Tuesday, April 24th. Craig Hallum restated a “buy” rating and issued a $94.00 target price (up previously from $87.00) on shares of Zoetis in a research note on Wednesday, April 25th. BMO Capital Markets restated a “hold” rating and issued a $80.00 target price on shares of Zoetis in a research note on Wednesday, May 16th. Jefferies Financial Group set a $96.00 target price on shares of Zoetis and gave the stock a “buy” rating in a research note on Friday, July 13th. Finally, Bank of America raised their target price on shares of Zoetis from $97.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday, July 30th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and twelve have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $90.53.

The company has a current ratio of 4.38, a quick ratio of 2.92 and a debt-to-equity ratio of 2.50. The firm has a market cap of $44.18 billion, a PE ratio of 37.94, a PEG ratio of 1.88 and a beta of 1.02.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Thursday, August 2nd. The company reported $0.77 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.71 by $0.06. The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.38 billion. Zoetis had a net margin of 19.95% and a return on equity of 72.30%. The business’s revenue was up 11.5% compared to the same quarter last year. During the same quarter last year, the firm posted $0.53 EPS. analysts expect that Zoetis Inc will post 3.07 earnings per share for the current year.

Several institutional investors and hedge funds have recently made changes to their positions in ZTS. HL Financial Services LLC increased its holdings in shares of Zoetis by 8.2% in the 1st quarter. HL Financial Services LLC now owns 136,761 shares of the company’s stock valued at $11,421,000 after purchasing an additional 10,333 shares in the last quarter. FDx Advisors Inc. increased its holdings in shares of Zoetis by 35.8% in the 1st quarter. FDx Advisors Inc. now owns 92,021 shares of the company’s stock valued at $7,685,000 after purchasing an additional 24,280 shares in the last quarter. Wells Fargo & Company MN increased its holdings in Zoetis by 10.0% during the 1st quarter. Wells Fargo & Company MN now owns 5,845,480 shares of the company’s stock valued at $488,156,000 after acquiring an additional 531,837 shares in the last quarter. Daiwa Securities Group Inc. increased its holdings in Zoetis by 26.7% during the 1st quarter. Daiwa Securities Group Inc. now owns 21,320 shares of the company’s stock valued at $1,779,000 after acquiring an additional 4,492 shares in the last quarter. Finally, Meag Munich Ergo Kapitalanlagegesellschaft MBH increased its holdings in Zoetis by 28.0% during the 1st quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH now owns 59,572 shares of the company’s stock valued at $4,805,000 after acquiring an additional 13,034 shares in the last quarter. Institutional investors and hedge funds own 90.98% of the company’s stock.

About Zoetis (NYSE:ZTS)

Zoetis Inc discovers, develops, manufactures, and markets veterinary vaccines and medicines in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.

Recommended Story: Trading Strategy Methods and Types

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.